|
English
|
正體中文
|
简体中文
|
2832487
|
|
???header.visitor??? :
33864773
???header.onlineuser??? :
1401
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"dito e"???jsp.browse.items-by-author.description???
Showing items 1-3 of 3 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國立成功大學 |
2013-08-20 |
A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer
|
Ko, A. H.; Tempero, M. A.; Shan, Y-S; Su, W-C; Lin, Y-L; Dito, E.; Ong, A.; Wang, Y-W; Yeh, C. G.; Chen, L-T |
| 國家衛生研究院 |
2013-08 |
A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer
|
Ko, AH;Tempero, MA;Shan, YS;Su, WC;Lin, YL;Dito, E;Ong, A;Wang, YW;Yeh, CG;Chen, LT |
| 國家衛生研究院 |
2011-02 |
A multinational phase II study of liposome irinotecan (PEP02) for patients with gemcitabine-refractory metastatic pancreatic cancer
|
Ko, AH;Tempero, MA;Shan, Y;Su, W;Lin, Y;Dito, E;Ong, A;Yeh, G;Chen, L |
Showing items 1-3 of 3 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
